2019 CYIR Finalized

55 Comments 1. ICU nurses were trained to deploy a complex psychological support intervention rooted in Cognitive Behavioral Therapy for ICU patients with stress symptoms. 2. In a large, multi-site, cluster-randomized, intention-to-treat, randomized trial, the intervention of the promotion of a thera- peutic environment around the patient and deployment of nurse-delivered Cognitive Behavioral Therapy for stressed ICU patients did not improve PTSD symptoms, days alive from sedation, ICU length-of-stay, mood symptoms, and/or health- related quality of life. 3. Among stressed patients in the ICU in the study, 63.7% received 3 CBT sessions, 16.6% received 2 sessions, 10.6% received 1 session, and 9.0% received 0 sessions. 4. Explanation for the negative study results could include: innate treatment ineffectiveness, incomplete training of ICU nurses in the CBT techniques, insufficient treatment dose, suboptimal timing of treatment and/or choice of a population unlikely/ unable to optimally benefit from the treatment. SITE OF DEATH Teno JM, Gozalo P, Trivedi AN, Bunker J, Lima J, Ogarek J, Mor V. Site of death, place of care, and health care tran- sitions among US Medicare beneficiaries, 2000-2015. JAMA 2018; 320(3):264-71. Summary For nearly two decades, JM Teno and collaborators have used Medicare enrollment and claims data and nursing home assessment data from the Centers for Medicare & Medicaid Services (CMS) Minimum Data Set to track site of death, place of care, and health care trajectory among Medicare U.S. decedents; previous reports were published in 2003 and 2013. This publication updates the dataset to include data points of 2000, 2005, 2009, 2011, and 2015. Results were summarized across 1,361,879 decedents with Medicare fee-for-service (MFS) from 2000-2015 and 871,845 decedents with Medicare Advantage (MA) from 2011-2015. Among MFS decedents, mean age at death increased from 81.9 in 2000 to 83.5 in 2015 and MA dece- dents had a mean age at death of 82.0 in 2011 and 82.1 in 2015. Among MFS decedents from 2000 to 2015, hospice services at time of death increased from 21.6% to 50.4%, but ICU use during the last 30 days-of-life increased from 24.3% to 29.1% in 2011 and stayed stable at 29.0% in 2015. Among MFS decedents, patients with health care transitions during the last 3 days-of-life increased from 10.3% in 2000 to 14.2% in 2009 but then subsided to 11.2% in 2011 and 10.8% in 2015. Comments 1. From 2000 to 2015, fewer MFS decedents died in an acute care hospital (32.6% to 19.8%) and more utilized hospice services at time of death (21.6% to 50.4%). 2. Though hospice use from 2000-2015 among MFS decedents increased, the rate of ICU use during the last month of life also increased from 2000-2009 (24.3% to 29.2%) and stayed stable from 2009 to 2015 (29.2% to 29.0%). 3. Though the MA dataset (2011-2015) was smaller than the MFS dataset (2000-2015), findings were similar between the datas- ets for the available and concurrent time periods although MA decedents were less likely to die in a nursing home, more likely to die at home or in a community setting, and less likely to be hospitalized during the last 30 and 90 days-of-life (9.3% reduc- tion of hospitalization in last 30 days-of-life between MA and MFS groups in 2015). 4. In 2015, among MFS decedents with a late hospice referral (< 3 days before death), 42.9% were admitted directly from a hospitalization involving an ICU stay. UNDERTREATMENT OF ICU DYSPNEA Gentzler ER, Derry H, Ouyang DJ, Lief L, Berlin DA, Xu CJ, Maciejewski PK, Prigerson HG. Underdetection and undertreatment of dyspnea in critically ill patients. Am J Resp Crit Care Med. 2018 Nov 28. Epub ahead of print. Summary The prevalence and management of ICU-related dyspnea and pain are unclear. At a single, urban, academic center from June 2016-April 2018, this team completed an obser- vational study evaluating dyspnea and pain prevalence and management among 138 hospitalized patients who were admitted to the MICU, fluent in English, and able to consent or having a caregiver proxy for consent. In total, 144 of 207 eligible patients (69.6%) were enrolled with 101 caregivers and 46 of 50 (92%) ICU nurses enrolled. Within a half-hour of each other, the patient, caregiver, and nurse were daily asked to rate the patient’s dyspnea and pain on a 0-10 Numeric Rating Scale (NRS) for each symptom. Data on nurse medication administration for the following 12 hours were abstracted from the medical record. An NRS of ≥ 4 for either symptom was considered to be “significant.” Among patients, 47% and 41% reported significant dyspnea and pain, respectively. In contrast, 61% and 46% of caregiv- ers and 34% and 22% of nurses reported patients having significant dyspnea and pain, respectively. As compared to patients with non-significant nurse-rated pain, patients with significant nurse-rated pain were 2.7 times more likely to get opioids. Patients with significant nurse-rated dyspnea were not more likely to get opioids (OR=0.72, [0.35, 1.46]). Caregiver ratings of dyspnea correlated better with patient ratings (kappa=0.19, p<0.001) as compared to nurse- patient ratings correlation (kappa=0.19, p=0.39). Comments 1. In this single site, observational study, a high proportion (47%) of MICU patients had significant self-rated dyspnea and as compared to nurse ratings, caregiver ratings of patient dyspnea were more accurate (kappa=0.19, p<0.001 versus kappa=0.19, p=0.39). 2. In total, 89 of the 138 study patients (65%) were receiving mechanical ventilation (by tracheostomy or endotracheal tube) at the time of the study with 19% of these patients able to rate their own symptoms. 3. Detection of dyspnea did not increase patient likelihood of receiving opioids (OR=0.72 [0.35,1.46]) nor administration of PALLIATIVE MEDICINE

RkJQdWJsaXNoZXIy MTM1ODMw